Analysts' average 12-month price target for ATAI Life Sciences N.V. is $9.2.
Get informed when a big investor buys or sells
+ Follow$7.29
6 analysts in the last 4 months
High: $17 | Low: $7.45
No recommendations in the last 4 months.
As of the most recent data, ATAI shows a target price of $9.2. Scroll down for historical charts and peer comparison views.
If ATAI Life Sciences N.V. moved to the average analyst target of $9.2, shares would be roughly 26.8% higher than $7.29. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of ATAI Life Sciences N.V.'s earnings trajectory.
Besides this target price page, Stockcircle has ATAI Life Sciences N.V.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $9.2) with ownership activity and broader fundamentals.
ATAI Life Sciences N.V.'s target price is $9.2; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.